HomeIVBXF • OTCMKTS
add
Innovent Biologics Inc
Previous close
$11.70
Day range
$11.72 - $11.72
Year range
$5.00 - $15.12
Market cap
158.77B HKD
Avg Volume
1.35K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.54B | 29.60% |
Operating expense | 2.72B | 36.07% |
Net income | -10.38M | -106.97% |
Net profit margin | -0.29 | -105.32% |
Earnings per share | — | — |
EBITDA | 39.42M | -71.11% |
Effective tax rate | 64.33% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.23B | 131.25% |
Total assets | 37.35B | 72.89% |
Total liabilities | 17.99B | 112.04% |
Total equity | 19.36B | — |
Shares outstanding | 1.71B | — |
Price to book | 1.03 | — |
Return on assets | -0.24% | — |
Return on capital | -0.40% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.38M | -106.97% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
CEO
Founded
Nov 28, 2011
Website
Employees
7,502
